Mono Pharmacare Q4 Results
- BSE: -
- NSE: MONOPHARMA
- ISIN: INE0OIP01012
- Sector: -
BSE
This stock is not traded on BSE
NSE
23.30
0.10 (0.43%)
0.10 (0.43%)Volume36.00 K
Updated: Thu 19 Jun, 2025 | 15:26:21
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Mono Pharmacare Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | - | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 55.81 | - | N/A | 35.03 | 59.32% |
| Selling/ General/ Admin Expenses Total | 1.70 | - | N/A | 0.88 | 92.97% |
| Depreciation/ Amortization | 0.06 | - | N/A | 0.07 | -8.17% |
| Other Operating Expenses Total | 1.27 | - | N/A | 0.81 | 57.93% |
| Total Operating Expense | 53.42 | - | N/A | 33.12 | 61.30% |
| Operating Income | 2.39 | - | N/A | 1.91 | 25.03% |
| Net Income Before Taxes | 0.87 | - | N/A | 1.03 | -15.87% |
| Net Income | 0.56 | - | N/A | 0.64 | -11.84% |
| Diluted Normalized EPS | 0.33 | - | N/A | 0.22 | 46.20% |